-
High oxaluria drug listing application is eligible for FDA priority review
On May 26th, Alnylam Pharmaceuticals announced that the FDA has accepted its marketing application for RNAi (RNAi) drug lumasiran for the treatment of...
2020-05-28 11:43 -
The world's first iron carrier cephalosporin drug is approved in the EU
The Japanese pharmaceutical company Shionogi recently announced that the European Commission (EC) has approved the new antibacterial drug Fetcroja (ce...
2020-05-28 11:18 -
WuXi upgrades CAR-T offerings with new manufacturing platform
So far, manufacturing has been a hurdle for drugmakers in the burgeoning CAR-T field—but WuXi AppTec is doing its best to change that.
2020-05-25 11:42 -
AstraZeneca signs up to deliver hundreds of millions of COVID-19 vaccines
Only days after Moderna reported positive early results for its potential COVID-19 vaccine, AstraZeneca has stolen the spotlight back. On Thursday, th...
2020-05-25 11:40 -
PolyOne launches new additives to enhance the filtering ability of masks
PolyOne, a specialty polymer material company in Ohio, USA, has released a new functional additive for protective masks, which can improve the filteri...
2020-05-25 09:33 -
U.S. signs huge API contract to reduce overseas dependence
Recently, the U.S. government has signed a $ 354 million contract with startup pharmaceutical company Phlow Corporation to produce and supply scarce g...
2020-05-22 11:50 -
Univercells inks deal to produce prefabricated vaccine facilities for potential
Manufacturing capacity has become a serious sticking point for drugmakers on the hunt for a COVID-19 vaccine as more industry insiders cast doubt on t...
2020-05-19 11:32 -
The first deuterated new drug Austedo, approved for listing in China
On December 27, 2019, the deuterated tetrabenazine tablets from Teva directly submitted a new drug marketing application (NDA) in China, and was accep...
2020-05-19 10:17 -
EU evaluates the safety of Panax notoginseng and Astragalus extract
Recently, at the request of the European Commission, the European Food Safety Authority (EFSA) Nutrition, New Food and Food Allergen Group (NDA) issue...
2020-05-19 10:15 -
Gilead may struggle to expand remdesivir's market to moderately ill COVID-19
Gilead Sciences had barely rushed its COVID-19 drug remdesivir into mass production when it started touting the potential benefits of alternate formul...
2020-05-18 16:51
Hot News
- Heubach GmbH required to files... Apr 24, 2024
- Huadong Medicine Achieves Stro... Apr 19, 2024
- Pursell biodegradable coating ... Apr 24, 2024
- BMS (Bristol-Myers Squibb) Ann... Apr 28, 2024
- Breaking the Market: The Pheno... Apr 28, 2024
Related Products